Petros Pharmaceuticals In... (PTPI)

NASDAQ: PTPI · Real-Time Price · USD

0.25

-0.02 (-7.41%)

At close: May 02, 2025, 2:17 PM

Petros Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-14.32M	-8.16M	-20.04M	-8.99M	-20.59M	-32.51M	-32.47M
Depreciation & Amortization	2.94M	3.42M	5.6M	6.88M	6.66M	5.29M	8.06M
Stock-Based Compensation	197.22K	417.23K	1.2M	1.31M	n/a	n/a	n/a
Other Working Capital	1.78M	752.72K	-231.14K	-3.67M	-5.8M	7.58M	3.85M
Other Non-Cash Items	4.05M	-4.08M	3.75M	186.82K	2.02M	11.9M	42.55M
Deferred Income Tax	n/a	n/a	n/a	-9.48M	-1.43M	-645.87K	-6.94K
Change in Working Capital	4.53M	789.05K	-3.3M	-1.76M	-5.6M	13.09M	4.93M
Operating Cash Flow	-2.6M	-7.63M	-12.8M	-11.86M	-15.31M	2.53M	8.02M
Capital Expenditures	-24.59K	-1	n/a	n/a	-4.63K	-71.54K	-1.88M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-24.59M	n/a	n/a	n/a	-4.63M	n/a	n/a
Investing Cash Flow	-24.59M	n/a	n/a	n/a	-4.63K	-71.54K	-1.88M
Debt Repayment	-765.28K	-1.46M	-1.62M	-7.19M	8.78M	-3.11M	-2.55M
Common Stock Repurchased	n/a	-2M	n/a	n/a	n/a	n/a	n/a
Dividend Paid	-1.29B	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-5.7B	15M	n/a	4.01M	21.52M	-2.9M	n/a
Financial Cash Flow	-7B	11.54M	-1.62M	18.57M	30.3M	-3.11M	-2.55M
Net Cash Flow	-9.63M	3.91M	-14.42M	6.71M	14.99M	-648.31K	3.6M
Free Cash Flow	-2.63M	-7.63M	-12.8M	-11.86M	-15.31M	2.46M	6.15M